<2025年>

英文原著

●Neshige S, Takahashi N, Maruyama H. 
Wind Swirl Pattern on Density Spectral Array in Anti-GABAB Receptor Encephalitis With Amnestic Seizures. JAMA Neurol. Dec 22, 2025. Online ahead of print.

 

●Sato T, Neshige S, Togo M, Matsubara S, Ikeda S, Yamamoto A, Ashizaki T, Ishibashi H, Ohno N, Nonaka M, Matsuura H, Katagiri M, Terasawa Y. 
Application of the 2HELPS2B score with short-duration EEG for seizure prediction in acute impaired consciousness: A multicenter study. J Neurol Sci. 479: 125665, 2025. 

 

●Yokosaki M, Neshige S, Maruyama H. 
Leptomeningeal carcinomatosis presenting with multiple sulcal FLAIR hyperintensities and incomplete Cushing's triad. BMJ Case Rep. 18(9): e267235, 2025. 

 

●Tsuchigauchi S, Matsushige T, Hashimoto Y, Hosogai M, Takahashi H, Kobayashi S, Shishido T, Hara N, Kaneyoshi K, Uchida S, Maki R, Yamashita H.

Potential of low apolipoprotein A-I as a surrogate marker of vulnerable carotid artery plaques. J Stroke Cerebrovasc Dis. 34(4): 108231, 2025.

 

●Yamada H, Nakamori M, Oda M, Toko M, Sakahara H, Tagane Y, Yamazaki Y, Izumi Y, Maruyama H. 

Time-course assessment of oral intake function and its impact on end-of-life in older individuals over 90 years with frailty. Geriatr Gerontol Int. 25(1): 96-101, 2025.

 

●Eto F, Nezu T, Sakahara H, Yamamoto Y, Aoki S, Shimomura M, Karakawa S, Maruyama H.

Intravenous Thrombolysis for Pediatric Ischemic Stroke Secondary to Cancer Therapy-related Cardiac Dysfunction: A Case Report. Intern Med. 64(2): 287-291, 2025.

 

●Yorichika Y, Neshige S, Sakahara H, Ono N, Nonaka M, Tagane Y, Watanabe T, Tachiyama K, Ishibashi H,
 Nakamori M, Shishido T, Aoki S, Ueno H, Yamazaki Y, Iizuka T, Maruyama H.

Early initiation of intravenous cyclophosphamide and one-year outcome in super-refractory cryptogenic-new onset refractory status epilepticus. Epilepsia Open. 10(1): 307-313, 2025.

 

●Toko M, Ohshita T, Nakamori M, Ueno H, Akiyama Y, Maruyama H.

Myelin measurement in amyotrophic lateral sclerosis with synthetic MRI: A potential diagnostic and predictive method. Journal of the Neurological Sciences. J Neurol Sci. 468: 123337, 2025.

 

●Toko M, Nezu T, Eto F, Aoki S, Ohshita T, Ueno H, Akiyama Y, Maruyama H.

Usefulness of Myelin Quantification Using Synthetic Magnetic Resonance Imaging for Predicting Outcomes in Patients With Acute Ischemic Stroke. Stroke. 56(3): 649-656, 2025.

 

●Naito H, Nakamori M, Toko M, Hayashi Y, Tazuma T, Watanabe T, Ishihara K, Tachiyama K, Yamazaki Y, Maruyama H.

A single-center, single-arm, prospective, open-label, and comparative trial to evaluate the safety and tolerability profile of a 90-day oral L-arginine hydrochloride intervention for patients with amyotrophic lateral sclerosis. Sci Rep. 15(1): 1120, 2025.

 

●Yokosaki M, Neshige S, Takahashi N, Aoki S, Maruyama H.

Seizure clusters with typical "evolution" in EEG. QJM. 118(7): 530-531, 2025.

 

●Yoshikawa H, Neshige S, S, Kagawa K, Sato S, Nishigakiuchi R, Fujii K, Maruyama H, Iida K, Matsuo H.

A Survey on the Awareness of Epilepsy Treatments in Community Pharmacies. Cureus 17(2): e79249, 2025.

 

●Ohno N, Neshige S, Nonaka M, Yamada H, Takebayashi Y, Ishibashi H, Aoki S, Yamazaki Y, Iida K, Maruyama H.

Alpha-band activity in density spectral array predictive for neurological outcome in patients with hypoxic-ischemic encephalopathy. Clin Neurol Neurosurg. 250: 108791, 2025.

 

●Neshige S, Takebayashi Y, Ishikawa R, Ohno N, Iida K, Maruyama H, Tabuchi T. Presenteeism in people with previous and current epilepsy: Determinants and psychosocial associations. Seizure. 125: 16-22, 2025.

 

●Wada S, Koga M, Kagimura T, Toyoda K, Nagai Y, Aoki S, Nezu T, Hosomi N, Origasa H, Ohtsuki T, Maruyama H, Yasaka M, Kitagawa K, Uchiyama S, Minematsu K, Matsumoto M; Japan Statin Treatment Against Recurrent Stroke (J-STARS) Echo Study Collaborators.

Long-term changes in carotid intima-media thickness according to baseline blood pressure level: J-STARS Echo study. J Neurol Sci. 468: 123342, 2025.

 

●Aoki S, Nishi H, Shiga Y, Nezu T, Eto F, Imamura E, Shimomura R, Kawada-Matsuo M, Komatsuzawa H, Kawaguchi H, Maruyama H. Fusobacterium nucleatum in the oral cavity is associated with cerebral small vessel disease in patients with ischemic stroke.J Stroke Cerebrovasc Dis. 34(1): 108183, 2025.

 

●Maetani Y, Kurashige T, Tada Y, Kume K, Watanabe T, Sotomaru Y, Yamanaka K, Maruyama H, Kawakami H.

Optineurin knock-out forms TDP-43 aggregates to regulate TDP-43 protein levels despite autophagic up-regulation and aberrant TDP-43 expression. Neurosci Res. 216: 104893, 2025.

 

●Kurashige T, Murao T, Kanaya Y, Dodo Y, Sugiura T, Kuraoka K, Ohshita T.

Intramuscular Nerve Bundles Reflect TDP-43 Pathology in the Medulla and Spinal Cord of ALS Patients. Neuropathol Appl Neurobiol. 51(2): e70016, 2025.

 

●Ishikawa R, Sugimoto T, Ohno N, Iizuka T, Nomura E.

A Case of Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Encephalitis With Video-Documented Psychogenic Nonepileptic Seizures (PNES)-Mimicking Episodes Initially Considered as Somatic Symptom Disorder.. Cureus. 17(2): e79384, 2025.

 

●Muguruma K, Takahashi T, Tagane Y, Nazere K, Hara N, Nakamori M, Yamazaki Y, Morino H, Maruyama H.

Intracellular anionic substances cause tau liquid-liquid phase separation. Biochem Biophys Res Commun. 757: 151605, 2025.

 

●Yagi S, Kadota M, Bando R, Miyamoto R, Morino H, Kakutani A, Kubo Y, Ise T, Ueno R, Hara T, Kusunose K, Yamaguchi K, Yamada H, Soeki T, Wakatsuki T, Fukuda D, Sata M.

Pulmonary Arterial Hypertension in Neurofibromatosis Type 1: A Case with a Novel NF1 Gene Mutation. Intern Med. 64(5): 725-728, 2025.

 

●Osaki Y, Nodera H, Sato R, Haji S, Fujita K, Miyamoto R, Muto K, Yamazaki H, Morino H, Kanda T, Murayama S, Kaji R, Izumi Y.

Peripheral nerve excitability abnormalities in Neuronal Intranuclear Inclusion Disease: Assessment with histopathological analysis. Clin Neurophysiol. 170: 156-167, 2025.

 

●Matsunaga K, Yoshida-Tsuboi A, Inohara K, Yoshida Y, Nakahama K, Sasaki K, Souda F, Terasawa Y, Shimoe Y, Takeuchi-Hatanaka K, Yamamoto T, Omori K, Kohriyama T, Takashiba S.

Effectiveness of oral health care intervention for stroke patients following the introduction of Oral Health Assessment Tool. Geriatr Gerontol Int. Jan;25(1): 48-53, 2025.

 

●Neshige S, Aoki S, Ohno N, Abe T, Nonaka M, Takebayashi Y, Ishibashi H, Shishido T, Agari D, Iida K, Maruyama H.

Clinico-psychosocial prediction for seizure emergencies: A multicenter derivation-validation study. Seizure. 131: 307-313, 2025. 

 

●Ohno N, Neshige S, Abe T, Nonaka M, Yamada H, Takebayashi Y, Ishibashi H, Shishido T, Aoki S, Yamazaki Y, Ueno H, Iida K, Maruyama H.

Screening of toxic-metabolic encephalopathy with and without epileptic seizure with density spectral array. J Neurol Sci. 472: 123462, 2025.

 

●Ohno N, Nezu T, Maruyama H.

Diplopia Secondary to Parieto-occipital Lobe Hemorrhaging. Intern Med. 2025 Nov 13. Online ahead of print.

 

●Nakamori M, Imamura E, Matsushima H, Tachiyama K, Ayukawa T, Nishino M, Yoshikawa M, Yoshida M, Maruyama H.

Relationships between dysarthria, lesion location, and oral/swallowing function in patients with first-ever stroke. Clin Neurol Neurosurg. 254: 108928, 2025.

 

●Neshige S, Sakahara H, Maruyama H.

Rhythmic Delta Activity beyond Neuroleptic Malignant Syndrome. Intern Med. 64(9): 1446-1447, 2025.

 

●Kaneyoshi K, Nezu T, Aoki S, Ishii D, Imamura E, Shimomura R, Mizoue T, Yamashita H, Hara N, Matsushige T, Nomura E, Kono T, Hirotsune N, Ochi K, Naka H, Kinoshita N, Tominaga A, Kiura Y, Horie N, Maruyama H.

Indicators associated with outcomes of in-hospital ischemic stroke. Clin Neurol Neurosurg. 258: 109160, 2025.

 

●Yokosaki M, Neshige S, Maruyama H.

Leptomeningeal carcinomatosis presenting with multiple sulcal FLAIR hyperintensities and incomplete Cushing's triad. BMJ Case Rep. 18(9): e267235, 2025.

 

●Naito H, Nakamori M, Nishi H, Toko M, Muguruma T, Yamada H, Sugimoto T, Yamazaki Y, Ochi K, Kawaguchi H, Maruyama H.

The periodontal pathogen Fusobacterium nucleatum is associated with disease severity in multiple sclerosis. Sci Rep. 15(1): 38316, 2025.

 

●Nishikawa Y, Watanabe K, Holobar A, Takahashi T, Maeda N, Maruyama H, Hyngstrom A.

Sex Differences in Motor Unit Behavior in Patients With Parkinson's Disease. Hyngstrom A. Eur J Neurosci. 62(1): e70191, 2025.

 

●Tachiyama K, Kanbayashi T, Kawabata A, Hoshino S, Miyaji Y, Kobayashi S, Maruyama H, Sonoo M.

Pitfalls of the E-Ref Procedure: Tie Values and the Proportion of the Abnormal Data. Muscle Nerve. 71(3): 435-441, 2025.

 

●Nakamori M, Tachiyama K, Matsumura N, Hironaka A, Muraoka Y, Kitagawa T, Tasaki M, Yamakawa S, Ueda M, Maruyama H.

Hereditary transthyretin amyloidosis with cardiomyopathy and polyneuropathy associated with a novel pathogenic TTR Tyr105His (p.Tyr125His) mutation. Amyloid. 32(4): 375-378, 2025.

 

●Ishihara K, Naito H, Sugimoto T, Nakamori M, Yamazaki Y, Ochi K, Maruyama H.

Comparison of prednisolone monotherapy vs. tacrolimus combination in NMOSD: Efficacy, safety, and optimal therapeutic timing. J Neuroimmunol. 408: 578737, 2025.

 

●Yokosaki M, Neshige S, Maruyama H.

Boiled Sausage Sign: A Novel MRI Marker for Identifying Subacute Secondary Hydrocephalus in the Elderly. Cureus. 17(3): e80587, 2025.

 

●Tachiyama K, Sugimoto T, Motoda A, Kurashige T, Aoki S, Maruyama H.

Vasculitic Neuropathy With Iron Deficiency-Related Chronic Inflammation Followed by Elevated Serum Vascular Endothelial Growth Factor: A POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes) Syndrome Mimic. Cureus. 17(6): e85384, 2025.

 

●Matsubara T, Izumi Y, Hatanaka Y, Takahara M, Kondo A, Matsukura K, Arakawa A, Haga T, Miyamoto R, Naruse H, Morino H, Toda T, Murayama S, Saito Y.

A Novel Neuropathological Subtype of Amyotrophic Lateral Sclerosis Characterised by Prominent Astroglial TDP-43 Pathology. Neuropathol Appl Neurobiol. 51(5): e70036, 2025.

 

●Miyashita A, Obinata A, Hara N, Mitsumori R, Kaneda D, Hashizume Y, Sano T, Takao M, Gabdulkhaev R, Tada M, Kakita A, Arakawa A, Morishima M, Murayama S, Saito Y, Hatsuta H, Matsubara T, Akagi A, Riku Y, Miyahara H, Sone J, Yoshida M, Yamaguchi H, Tsukie T, Hasegawa M, Kasuga K, Kikuchi M, Akatsu H, Kuwano R, Iwatsubo T; Japanese Alzheimer's Disease Neuroimaging Initiative; Niida S, Ozaki K, Ikeuchi T.

Association of rare APOE missense variants with Alzheimer's disease in the Japanese population. J Alzheimers Dis. 106(1): 363-377, 2025.

 

●Yamazaki H, Takamatsu N, Matsubara T, Tani M, Fukushima K, Yoshida T, Osaki Y, Oki R, Fujita K, Nodera H, Izumi Y.

Evaluation of the diagnostic performance of brachial plexus ultrasound in amyotrophic lateral sclerosis. Clin Neurophysiol. 175: 2110741, 2025.

 

●Sengoku R, Arakawa A, Matsubara T, Kameyama M, Tokumaru AM, Ishii K, Kanemaru K, Tarutani A, Hasegawa M, Iwata A, Murayama S, Saito Y.

Argyrophilic Grain Disease Clinically Presenting as Progressive Supranuclear Palsy with Progressive Gait Freezing. Mov Disord Clin Pract. 12(8): 1167-1172, 2025.

 

●Arakawa A, Matsubara T, Shioya A, Hara M, Hiroyoshi Y, Kurihara M, Morimoto S, Kato T, Higashihara M, Sengoku R, Kameyama M, Kanemaru K, Tokumaru AM, Arai T, Hara N, Miyashita A, Ikeuchi T, Tarutani A, Hasegawa M, Iwata A, Toda T, Murayama S, Saito Y.

Argyrophilic grain disease: epidemiology and association with cognitive decline and parkinsonism. Brain Commun. 7(5): fcaf352, 2025.

 

●Mochizuki Y, Arakawa A, Osako M, Matsubara T, Arai T, Saito Y.

A DRPLA-Affected Family: Clinical Course and Autopsy Findings in a Long-Surviving Case. Neuropathology. 45(4): e70007, 2025.

 

●Haji S, Sako W, Hanada K, Matsubara T, Osaki Y, Matsumoto Y, Harada M, Izumi Y.

Magnetic Susceptibility and Area in the Subthalamic Nucleus Measured by QSM for Diagnosis of Progressive Supranuclear Palsy. Mov Disord Clin Pract. 12(10): 1602-1608, 2025.

 

●Tomenaga T, Minatani S, Namba H, Takeda A, Yoshizaki T, Kawabe J, Keyoumu N, Morino H, Higuchi M, Matsubara T, Hatsuta H, Hasegawa M, Murayama S, Itoh Y.

An autopsy case of type A FTLD-TDP with a GRN mutation presenting with the logopenic variant of primary progressive aphasia at onset and with corticobasal syndrome subsequently. Neuropathology. 45(1): 38-47, 2025.

 

●Tsuchigauchi S, MatsushigeT, Hashimoto Y, Hosogai M, Takahashi H, Oku S, Shishido T, Hara N, Kaneyoshi K,
Maki R, Kubota Y, Yamashita H.

Efficacy of carotid artery stenting in patients with symptomatic low-grade carotid artery stenosis. J Neurosurg. 144(2): 400-407, 2025.

 

●Yamakami K, Matsubara T, Fujita K, Nakamura K, Kihara N, Sogawa K, Nakao R, Hanada K, Yamamoto Y, Haji S, Otomi Y, Harada M, Izumi Y.

Identification of Hasegawa Dementia Scale-Revised Cutoff Scores Associated With Mini-Mental State Examination Thresholds for Anti-Amyloid β Therapies in Patients With Amnesia. Psychogeriatrics. 25(6): e70107, 2025.

 

●Yamazaki H, Sato R, Matsubara T, Takamatsu N, Osaki Y, Kanda T, Izumi Y.

Sarcoid Neuropathy Presenting with Two Novel Ultrasound Findings of Increased Intraneural Blood Flow and Small Saphenous Vein Wall Thickening. Intern Med. 64(18): 2779-2783, 2025.

 

英文総説

●Sekiya H, Matsubara T, DeTure MA, Dickson DW.

Neuropathology of Lewy body dementia: Lewy-related pathology, α-synuclein oligomers,and comorbid pathologies. Mol Neurodegener. 20(1): 117, 2025.

 

<2024年>

英文原著

●Gohara D, Neshige S, Sakahara H, Ohno N, Maruyama H.

Therapeutic Time Window With DWI-ADC (Diffusion-Weighted Imaging-Apparent Diffusion Coefficient) Match and Periodic Discharges for Status Epilepticus. Cureus. 16(2): e53811, 2024.

 

●Imon K, Neshige S, Maeda A, Yamamoto Y, Maruyama H.

Irregular Tremulous Movements and Infrequent Seizures: A Clinical-Electrophysiological Diagnosis of Benign Adult Familial Myoclonus Epilepsy. Cureus. 16(3): e56303, 2024.

 

●Atsuji K, Neshige S, Ohno N, Maruyama H.

Chronic Visual Abnormality in an Elderly Patient With Temporal Lobe Epilepsy. Cureus. 16(3): e56696, 2024.

 

●Yorichika Y, Neshige S, Edahiro T, Aoki S, Maruyama H.

An Early Neurological Indicator of Immune Effector Cell-Associated Neurotoxicity Syndrome. Cureus. 16(3): e57298, 2024.

 

●Eto F, Nezu T, Aoki S, Kuzume D, Hosomi N, Maruyama H.

Liver fibrosis index is associated with functional outcome among acute ischemic stroke patients. J Stroke Cerebrovasc Dis. 33(2): 107537, 2024.

 

●Eto F, Toko M, Takahashi S, Maruyama H.

Cortical Reflex Myoclonus in a Patient with Hyperammonemic Encephalopathy. Balkan Med J. 41(2): 145-146, 2024.

 

●Yamada H, Yamazaki Y, Takebayashi Y, Yazawa K, Sasanishi M, Motoda A, Nakamori M, Morino H, Takahashi T, Maruyama H.

The long-term effects of heated tobacco product exposure on the central nervous system in a mouse model of prodromal Alzheimer's disease. Sci Rep. 14(1): 227, 2024.

 

●Yamada H, Neshige S, Nonaka M, Takebayashi Y, Ishibashi H, Motoda A, Aoki S, Yamazaki Y, Maruyama H.

On-scene time delays for epileptic seizures in developed community-based integrated care system regions. Epilepsy Behav. 151: 109612, 2024.

 

●Nakamori M, Toko M, Yamada H, Hayashi Y, Ushio K, Yoshikawa K, Haruta A, Hiraoka A, Yoshikawa M, Nagasaki T, Mikami Y, Maruyama H.

Association between motor symptoms of Parkinson’s disease and swallowing disorders. Neurological Sciences. 45(5): 2021-2026, 2024.

 

●Eto F, Nezu T, Nishi H, Aoki S, Tasaka S, Horikoshi S, Yano K, Kawaguchi H, Maruyama H.

Oral condition at admission predicts functional outcomes and hospital-acquired pneumonia development among acute ischemic stroke patients, CLINICAL ORAL INVESTIGATIONS, 28(8): 434, 2024.

 

●Sugimoto T, Suzuki S, Uzawa A, Yamawaki T, Masuda M, Minami N, Kawaguchi N, Kubota T, Takahashi MP, Suzuki Y, Watanabe G, Konno S, Kimura T, Samukawa M, Ishizuchi K, Akamine H, Onishi Y, Yasuda M, Nagane Y, Maruyama H, Murai H, Utsugisawa K.

Worsening of myasthenic symptoms associated with statins. J Neurol Sci. 464: 123154, 2024.

 

●Neshige S, Sakahara H, Maruyama H.

Rhythmic Delta Activity Beyond Neuroleptic Malignant Syndrome. Intern Med. 64(9):1446-1447, 2024.

 

●Ishibashi H, Kobayashi K, Yamanaka H, Tojima M, Oi K, Neshige S, Hitomi T, Matsuhashi M, Maruyama H, Takahashi R, Ikeda A.

Redefined giant somatosensory evoked potentials: Evoked epileptic complexes of excitatory and inhibitory components. Clin Neurophysiol. 164: 119-129, 2024.

 

●Morino H, Kurashige T, Matsuda Y, Ono M, Sahara N, Miyasaka T, Soeda Y, Shimada H, Yamazaki Y, Takahashi T, Izumi Y, Ito H, Maruyama H, Higuchi M, Arihiro K, Suhara T, Takashima A, Kawakami H.

Clinical and Pathological Features of FTDP-17 with MAPT p.K298_H299insQ Mutation. Mov Disord Clin Pract. 11(6): 720-727, 2024.

 

●Horinouchi T, Nezu T, Saita K, Date S, Kurumadani H, Maruyama H, Kirimoto H.

Transcutaneous auricular vagus nerve stimulation enhances short-latency afferent inhibition via central cholinergic system activation. Sci Rep. 14(1): 11224, 2024.

 

●Yamaoka M, Neshige S, Sasaki K, Maruyama H.

Multiple System Atrophy Masquerading as Drug-Resistant Orthostatic Hypotension. Cureus. 16(9): e69774, 2024.

 

●Tachiyama K, Naito H, Nakamori M, Aoki S, Maruyama H.

Pembrolizumab-associated Neuronopathy with Improved Lower Limb Somatosensory Evoked Potential After Intravenous Methylprednisolone Treatment: A Case Report. Intern Med. 64(9):1408-1411, 2024.

 

●Abe T, Maruyama S, Kaneyoshi K, Neshige S.

Varicella-zoster Virus Meningitis Besides Bacterial Otitis. Intern Med. 63(9): 1329-1330, 2024.

 

●Neshige R, Neshige S.

Mucuna beans administered through hydrogen-infused superheated steam in advanced Parkinson's disease. Clin Park Relat Disord. 10: 100252, 2024.

 

●Tojima M, Shimotake A, Neshige S, Okada T, Kobayashi K, Usami K, Matsuhashi M, Honda M, Takeyama H, Hitomi T, Yoshida T, Yokoyama A, Fushimi Y, Ueno T, Yamao Y, Kikuchi T, Namiki T, Arakawa Y, Takahashi R, Ikeda A.

Specific consistency score for rational selection of epilepsy resection surgery candidates. Epilepsia. 65(5): 1322-1332, 2024.

 

●Yamada H, Aoki S, Nezu T, Neshige S, Motoda A, Yamazaki Y, Maruyama H.

Emergency medical service response for cases of stroke-suspected seizure: A population-based study. J Stroke Cerebrovasc Dis. 33(6): 107681, 2024.

 

●Neshige S, Aoki S, Ohno N, Nonaka M, Yamada H, Takebayashi Y, Ishibashi H, Shishido T, Agari D, Yamazaki Y, Iida K, Maruyama H.

Interictal head-turning sign in patients with idiopathic generalized epilepsy during initial medical interview: A matched multicenter study. Epilepsy Behav. 160: 110039, 2024.

 

●Nonaka M, Neshige S, Ono N, Yamada H, Takebayashi Y, Ishibashi H, Aoki S, Yamazaki Y, Shishido T, Agari D, Ochi K, Iida K, Maruyama H.

Clinical manifestations and outcomes associated with a high 2HELPS2B score in patients with acute impaired consciousness. J Neurol Sci. 465: 123174, 2024.

 

●Nezu T, Eto F, Hironaka A, Aoki S, Neshige S, Tasaka S, Kirimoto H, Maruyama H.

Vagus nerve size determined via ultrasonography is associated with white matter lesions in patients with vascular risk factors. J Ultrasound. 27(3): 723-732, 2024.

 

●Nakamori M, Ortega Fernández O, Kayashita J, Yoshikawa M.

Editorial: New approaches to evaluation and management of dysphagia in neurological disease. Front Neurol. 15: 1467206, 2024.

 

●Nakamori M, Toko M, Yamada H, Hayashi Y, Ushio K, Yoshikawa K, Hiraoka A, Yoshikawa M, Nagasaki T, Shimizu Y, Mikami Y, Maruyama H.

Cervical percutaneous interferential current stimulation improves citric acid cough tests in patients with Parkinson's disease on medication. Sci Rep. 14(1): 11386, 2024.

 

●Naito H, Sugimoto T, Hironaka A, Nakamori M, Yamazaki Y, Ochi K, Maruyama H.

Diagnostic value of lower extremity ultrasonographic nerve enlargement for differentiating demyelinating Charcot-Marie-Tooth disease from chronic inflammatory demyelinating polyneuropathy. J Neurol Sci. 460: 122995, 2024.

 

●Imamura K, Izumi Y, Egawa N, Ayaki T, Nagai M, Nishiyama K, Watanabe Y, Murakami T, Hanajima R, Kataoka H, Kiriyama T, Nanaura H, Sugie K, Hirayama T, Kano O, Nakamori M, Maruyama H, Haji S, Fujita K, Atsuta N, Tatebe H, Tokuda T, Takahashi N, Morinaga A, Tabuchi R, Oe M, Kobayashi M, Lobello K, Morita S, Sobue G, Takahashi R, Inoue H.

Protocol for a phase 2 study of bosutinib for amyotrophic lateral sclerosis using real-world data: induced pluripotent stem cell-based drug repurposing for amyotrophic lateral sclerosis medicine (iDReAM) study. BMJ Open. 14(10): e082142, 2024.

 

●Nakamori M, Imamura E, Maetani Y, Yoshida M, Yoshikawa M, Nagasaki T, Masuda S, Kayashita J, Mizoue T, Wakabayashi S, Maruyama H, Hosomi N.

Prospective Observational Study for the Comparison of Screening Methods Including Tongue Pressure and Repetitive Saliva Swallowing With Detailed Videofluoroscopic Swallowing Study Findings in Patients With Acute Stroke. J Am Heart Assoc. 13(3): e032852, 2024.

 

●Yamada H, Toko M, Nakamori M, Ueno H, Aoki S, Sugimoto T, Yasutomi H, Nakamichi K, Maruyama H.

Progressive multifocal leukoencephalopathy associated with systemic lupus erythematosus: longitudinal observation of lymphocytes, JC virus in cerebrospinal fluid, and brain magnetic resonance imaging. J Neurovirol. 30(2): 197-201, 2024.

 

●Tokuyasu D, Suzuki S, Uzawa A, Nagane Y, Masuda M, Konno S, Kubota T, Samukawa M, Sugimoto T, Ishizuchi K, Oyama M, Yasuda M, Akamine H, Onishi Y, Suzuki Y, Kawaguchi N, Minami N, Kimura T, Takahashi MP, Murai H, Utsugisawa K.

Real-world experience with eculizumab and switching to ravulizumab for generalized myasthenia gravis. Ann Clin Transl Neurol. 11(5): 1338-1346, 2024.

 

●Uzawa A, Suzuki S, Kuwabara S, Akamine H, Onishi Y, Yasuda M, Ozawa Y, Kawaguchi N, Kubota T, Takahashi MP, Suzuki Y, Watanabe G, Kimura T, Sugimoto T, Samukawa M, Minami N, Masuda M, Konno S, Nagane Y, Utsugisawa K.

Taste disorders and alopecia in myasthenia gravis. BMC Neurol. 24(1): 139, 2024.

 

●Suzuki S, Uzawa A, Nagane Y, Masuda M, Konno S, Kubota T, Samukawa M, Ishizuchi K, Tokuyasu D, Handa H, Yasuda M, Kawaguchi N, Kimura T, Suzuki Y, Sugimoto T, Minami N, Takahashi MP, Murai H, Utsugisawa K.

Therapeutic Responses to Efgartigimod for Generalized Myasthenia Gravis in Japan. Neurol Clin Pract. 14(3): e200276, 2024.

 

●Naito H, Sugimoto T, Kimoto K, Abe T, Ohno N, Giga M, Kono T, Ueno H, Nomura E, Maruyama H.

Detection of episodic nocturnal hypercapnia in patients with neurodegenerative disorders. Sleep Breath. 28(1): 393-399, 2024.

 

●Nakamori M, Yoshikawa K, Toko M, Yamada H, Hayashi Y, Ushio K, Nishikawa Y, Mikami Y, Maruyama H.

High-density surface electromyography evaluation of the suprahyoid muscles in patients with Parkinson's disease. J Neurol Sci. 466: 123266, 2024.

 

●Yoshikawa K, Nakamori M, Ushio K, Toko M, Yamada H, Nishikawa Y, Fukuoka T, Maruyama H, Mikami Y.

Analysis of the suprahyoid muscles during tongue elevation: High-density surface electromyography as a novel tool for swallowing-related muscle assessment. J Oral Rehabil. 51(9): 1872-1880, 2024.

 

●Neshige S, Kuriyama M, Ota S.

Diffusion-weighted imaging findings predictive of postoperative recurrence of chronic subdural hematoma. Journal of the Neurological Sciences. 467: 123324, 2024.

 

●Yokosaki M, Agari D, Maetani Y, Ueno H, Nomura E.

Punctate Hippocampal Hyperintensities on Diffusion-Weighted Imaging Following Epileptic Seizures: A Case Report. Cureus. 16(11): e73163, 2024.

 

●Watanabe G, Takai Y, Nagane Y, Kubota T, Yasuda M, Akamine H, Onishi Y, Uzawa A, Kawaguchi N, Masuda M, Konno S, Amino I, Minami N, Kimura T, Samukawa M, Sugimoto T, Suzuki Y, Takahashi MP, Suzuki S, Murai H, Aoki M, Utsugisawa K.

Cutoffs on severity metrics for minimal manifestations or better status in patients with generalized myasthenia gravis. Front Immunol. 15: 1502721, 2024.

 

●Edahiro T, Ureshino H, Nakamori M, Shindo T, Ichinohe T.

Acalabrutinib and Obinutuzumab for Chronic Lymphocytic Leukemia Complicated With Peripheral Neuropathy. Cureus. 16(11): e74703, 2024.

 

●Kurashige T, Nakamura R, Murao T, Mine N, Sato M, Katsumata R, Kanaya Y, Dodo Y, Sugiura T, Ohshita T.

Atypical skin conditions of the neck and back as a dermal manifestation of anti-HMGCR antibody-positive myopathy. BMC Immunol. 25(1): 30, 2024.

 

●Yasuda M, Uzawa A, Kuwabara S, Suzuki S, Akamine H, Onishi Y, Ozawa Y, Kawaguchi N, Kubota T, Takahashi MP, Suzuki Y, Watanabe G, Kimura T, Sugimoto T, Samukawa M, Minami N, Masuda M, Konno S, Nagane Y, Utsugisawa K.

Corrigendum to "Clinical features and outcomes of patients with muscle-specific kinase antibody-positive myasthenia gravis in Japan" [Journal of Neuroimmunology 385 (2023) 578241]. J Neuroimmunol. 397: 578465, 2024.

 

●Miyatake S, Doi H, Yaguchi H, Koshimizu E, Kihara N, Matsubara T, Mori Y, Kunieda K, Shimizu Y, Toyota T, Shirai S, Matsushima M, Okubo M, Wada T, Kunii M, Johkura K, Miyamoto R, Osaki Y, Miyama T, Satoh M, Fujita A, Uchiyama Y, Tsuchida N, Misawa K, Hamanaka K, Hamanoue H, Mizuguchi T, Morino H, Izumi Y, Shimohata T, Yoshida K, Adachi H, Tanaka F, Yabe I, Matsumoto N.

Complete nanopore repeat sequencing of SCA27B (GAA-FGF14 ataxia) in Japanese. J Neurol Neurosurg Psychiatry. 95(12): 1187-1195, 2024.

 

●Kittaka M, Mizuno N, Morino H, Yoshimoto T, Zhu T, Liu S, Wang Z, Mayahara K, Iio K, Kondo K, Kondo T, Hayashi T, Coghlan S, Teno Y, Doan AAP, Levitan M, Choi RB, Matsuda S, Ouhara K, Wan J, Cassidy AM, Pelletier S, Nampoothiri S, Urtizberea AJ, Robling AG, Ono M, Kawakami H, Reichenberger EJ, Ueki Y.

Loss-of-function OGFRL1 variants identified in autosomal recessive cherubism families. JBMR Plus. 8(6): ziae050, 2024. 

 

●Yagi S, Miyamoto R, Tasaki M, Morino H, Otani R, Kadota M, Ise T, Yamazaki H, Kusunose K, Yamaguchi K, Yamada H, Soeki T, Wakatsuki T, Fukuda D, Ueda M, Sata M. The APOA1 p.Leu202Arg variant potentially causes autosomal recessive cardiac amyloidosis. Hum Genome Var. 11(1): 30, 2024.

 

●Hanada K, Osaki Y, Miyamoto R, Muto K, Haji S, Nazere K, Kuwano Y, Morino H, Azuma Y, Miyatake S, Matsumoto N, Izumi Y.

Intermediate phenotype between CMT2Z and DIGFAN associated with a novel MORC2 variant: a case report. Hum Genome Var. 11(1): 29, 2024.

 

●Itou T, Fujita K, Okuzono Y, Warude D, Miyakawa S, Mihara Y, Matsui N, Morino H, Kikukawa Y, Izumi Y.

Th17 and effector CD8 T cells relate to disease progression in amyotrophic lateral sclerosis: a case control study. J Neuroinflammation. 21(1): 331, 2024.

 

●Taniuchi R, Kanai S, Hara A, Monden K, Nagatani H, Torii T, Harada T.

Extraction of the pull force from inertial sensors during the pull test for Parkinson's disease: A reliability study. J Mov Disord. 17(2): 150-157, 2024.

 

●Eto F, Kono T, Kidani N, Taniguchi K, Ikemori T, Uchida S, Hirotsune N, Nomura E.

A case of carotid web with rapid thrombus expansion following mechanical thrombectomy with pathological evaluation by carotid endarterectomy. J Stroke Cerebrovasc Dis. 33(11): 107998, 2024.

 

<2023年>

英文原著

●Nakamori M, Ishikawa R, Watanabe T, Toko M, Naito H, Takahashi T, Simizu Y, Yamazaki Y, Maruyama H.

Swallowing sound evaluation using an electronic stethoscope and artificial intelligence analysis for patients with amyotrophic lateral sclerosis. Front Neurol. 14:1212024, 2023.

 

●Takebayashi Y, Yamazaki Y, Yamada H, Yazawa K, Nakamori M, Kurashige T, Morino H, Takahashi T, Sotomaru Y, Maruyama H.

Apolipoprotein E genotype-dependent accumulation of amyloid β in APP-knock-in mouse model of Alzheimer's disease. Biochem Biophys Res Commun. 683:149106, 2023.

 

●Kurashige T, Morino H, Ueno H, Murao T, Watanabe T, Hinoi T, Nishino I, Torii T, Maruyama H.

Gastrointestinal cancer occurs as extramuscular manifestation in FSHD1 patients. J Hum Genet. 68(2): 91-95, 2023.

 

●Yamada H, Neshige S, Morino H, Maruyama H.

Extubation failure due to atypical parkinsonism with negligible motor and variable non-motor symptoms associated with a variant of DCTN1. Intern Emerg Med. 18(1): 329-331, 2023.

 

●Uzawa A, Suzuki S, Kuwabara S, Akamine H, Onishi Y, Yasuda M, Ozawa Y, Kawaguchi N, Kubota T, Takahashi MP, Suzuki Y, Watanabe G, Kimura T, Sugimoto T, Samukawa M, Minami N, Masuda M, Konno S, Nagane Y, Utsugisawa K.

Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravis. J Neurol Neurosurg Psychiatry. 94(6): 467-473, 2023.

 

●Neshige S, Aoki S, Tomohisa N, Nakamori M, Yamazaki Y, Ohshita T, Maruyama H.

Are patients with Parkinson's disease at a lower risk of catching the common cold? Propensity score matching. Parkinsonism & Related Disorders. 106; 105227, 2023.

 

●Nonaka M, Neshige S, Yamada H, Ishibashi H, Takebayashi Y, Nakamori M, Aoki S, Yamazaki Y, Shishido T, Agari D, Ochi K, Iida K, Maruyama H.

Immediate and 6-month seizure outcomes following first and second SARS-CoV2 mRNA vaccinations: A multicenter study with a nationwide survey. Epilepsy Behav. 139: 109070, 2023.

 

●Yamada H, Neshige S, Nonaka M, Takebayashi Y, Ishibashi H, Motoda A, Aoki S, Yamazaki Y, Maruyama H.

On-scene time delays for epileptic seizures in emergencies during a social pandemic: A population-based study. Epilepsy Behav. 142: 109211, 2023.

 

●Takebayashi Y, Neshige S, Shishido T, Hayashi Y, Segawa A, Nakamori M, Nezu T, Aoki S, Yamazaki Y, Ueno H, Ohshita T, Iida K, Maruyama H.

Paradoxical effects of levetiracetam in people with epilepsy with rhythmic epileptiform discharges. Epilepsy Behav. 143: 109225, 2023. 

 

●Watanabe T, Nakamori M, Ishikawa K, Motoda A, Neshige S, Yamamoto S, Katahira K, Higaki T, Ueno H, Iizuka T, Maruyama H.

Reversible Brain Atrophy in Cryptogenic New-onset Refractory Status Epilepticus. Intern Med.　62(12): 1835-1842, 2023.

 

●Naito H, Sugimoto T, Kimoto K, Abe T, Ohno N, Giga M, Kono T, Ueno H, Nomura E, Maruyama H.

Detection of episodic nocturnal hypercapnia in patients with neurodegenerative disorders. Sleep Breath. Jul 8, 2023.

 

●Maeda A, Neshige S, Katsumata R, Nonaka M, Ishibashi H, Maruyama H.

Exacerbation of Repetitive Falls Due to Atonic Seizures Following Perampanel Administration. The Cureus Journal of Medical Science. 15(6): e40818, 2023.

 

●Takenaka M, Nakamori M, Ishikawa R, Aoki S, Maruyama H.

Encephalopathy after COVID-19 vaccination during treatment with nivolumab: A case report. Clinical Neurology and Neurosurgery. 226: 107632, 2023.

 

●Ishikawa R, Nakamori M, Takenaka M, Aoki S, Yamazaki Y, Hashiguchi A, Takashima H, Maruyama H.

Case report: Mitochondrial trifunctional protein deficiency caused by HADHB gene mutation (c.1175C>T) characterized by higher brain dysfunction followed by neuropathy, presented gadolinium enhancement on brain imaging in an adult patient. Front Neurol. 14:1187822, 2023.

 

●Sugimoto T, Kurokawa K, Naito H, Kono T, Nomura E, Maruyama H.

Features of repetitive nerve stimulation and nerve conduction studies in patients with amyotrophic lateral sclerosis. Neurology and Clinical Neuroscience. 11(3): 134-139, 2023.

 

●Ishibashi H, Kobayashi K, Tojima M, Neshige S, Hitomi T, Ishiura H, Tsuji S, Maruyama H, Takahashi R, Ikeda A.

Clinical diagnostic criteria of benign adult familial myoclonus epilepsy type 1 are highly concordant with genetic testing. Neurology and Clinical Neuroscience.  11(3): 140-145, 2023.

 

●Kume K, Kurashige T, Muguruma K, Morino H, Tada Y, Kikumoto M, Miyamoto T, Akutsu SN, Matsuda Y, Matsuura S, Nakamori M, Nishiyama A, Izumi R, Niihori T, Ogasawara M, Eura N, Kato T, Yokomura M, Nakayama Y, Ito H, Nakamura M, Saito K, Riku Y, Iwasaki Y, Maruyama H, Aoki Y, Nishino I, Izumi Y, Aoki M, Kawakami H.

CGG repeat expansion in LRP12 in amyotrophic lateral sclerosis. Am J Hum Genet. 110(7):1086-1097, 2023.

 

●Kamimura T, Nakamori M, Naito H, Aoki S, Nezu T, Imamura E, Mizoue T, Wakabayashi S, Masuda T, Hattori N, Maruyama H, Hosomi N.

Peak expiratory flow, but not tongue pressure, can predict pneumonia development in older adults. Eur Geriatr Med. 14(1): 211-217. 2023.

 

●Tojima M, Kobayashi K, Hitomi T, Ishibashi H, Yoshii D, Sainouchi M, Ayaki T, Shimotake A, Usami K, Maki T, Kakita A, Takahashi R, Ikeda A.

A super-elderly autopsy case of benign adult familial myoclonus epilepsy with a heterozygous mutation. Epileptic Disord. 25(1): 110-113, 2023.

 

●Matsubara T, Numata K, Inaba T, Maeno T.

Onlinization of a simulation course that includes minor emergency procedures. Acute Med Surg. 10(1): e883, 2023.

 

●Abe T, Maruyama S, Kaneyoshi K, Neshige S.

Varicella-zoster Virus Meningitis Besides Bacterial Otitis. Intern Med. 2518-23, 2023.

 

●Neshige S, Ohno N, Maruyama H.

Attacks With Urinary Incontinence Without Convulsions: Complete Atrioventricular Block Mimicking an Epileptic Seizure. Cureus. 15(11): e49552, 2023.

 

●Neshige S, Toko M, Aoki S, Maruyama H.

Density spectrum array and difficult to diagnose seizure activity. QJM: An International Journal of Medicine, 116(11): 947–948, 2023.

 

●Yamada H, Nakamori M, Kuga J, Hironaka A, Sugimoto T, Ueno H, Ohshita T, Morino H, Maruyama H.

Nerve Ultrasonography for the Diagnosis and Evaluation of Neuralgic Amyotrophy: A Case Report. Intern Med. 62(12): 1843-1847, 2023.

 

●Kamimura T, Aoki S, Nezu T, Eto F, Shiga Y, Nakamori M, Imamura E, Mizoue T, Wakabayashi S, Maruyama H.

Association between Carotid Wall Shear Stress-Based Vascular Vector Flow Mapping and Cerebral Small Vessel Disease. J Atheroscler Thromb. 30(9): 1165-1175, 2023.

 

 

 

<2022年>

英文原著

●Neshige S, Katsumata R, Tomohisa N, Aoki S, Maruyama H.

Screening for non-convulsive status epilepticus with density spectrum array in critical care EEG. QJM. 114(12): 893-894, 2022.

 

●Nakamori M, Matsushima H, Tachiyama K, Hayashi Y, Imamura E, Mizoue T, Wakabayashi S.

Association of ankle-brachial index with cognitive decline in patients with lacunar infarction. PLoS One. 17(2): e0263525, 2022.

 

●Nazere K, Takahashi T, Hara N, Muguruma K, Nakamori M, Yamazaki Y, Morino H, Maruyama H.

Amyloid Beta Is Internalized via Macropinocytosis, an HSPG- and Lipid Raft-Dependent and Rac1-Mediated Process. Front Mol Neurosci. 15: 804702, 2022.

 

●Nezu T, Hosomi N, Aoki S, Nishi H, Nakamori M, Shiga Y, Imamura E, Shintani T, Kawaguchi H, Maruyama H.

Assessment of Serum IgG Titers to Various Periodontal Pathogens Associated with Atrial Fibrillation in Acute Stroke Patients. J Stroke Cerebrovasc Dis. 31(3):106301, 2022.

 

●Sugimoto T, Ochi K, Yamawaki T, Naito H, Ohno N, Nomura E, Kohriyama T, Maruyama H.

Characteristics of cause of death and triggers for crisis in patients with myasthenia gravis. Neurol Clin Neurosci. 10(3): 147-154, 2022.

 

●Yamada H, Nakamori M, Nezu T, Kotozaki T, Kitamura J, Ohshita T, Sueda Y, Maruyama H.

Clinical Factors Predicting Voluntary Driving Cessation among Patients with Parkinson's Disease. Behav Neurol. 2022: 4047710, 2022.

 

●Naito H, Sugimoto T, Kurokawa K, Kimoto K, Abe T, Matsuoka C, Ohno N, Giga M, Kono T, Ueno H, Nomura E.

Changes in the amplitude decremental response to repetitive nerve stimulation following fast-acting treatment in patients with myasthenia gravis during hospitalization. Clinical and Experimental Neuroimmunology. 13(4): 272–279, 2022.

 

●Nezu T, Hosomi N, Aoki S, Naito H, Torii T, Kurashige T, Sugiura T, Kuzume D, Morimoto Y, Yoshida T, Yagita Y, Oyama N, Eto F, Shiga Y, Kinoshita N, Kamimura T, Ueno H, Ohshita T, Maruyama H.

Short-term or long-term outcomes for stroke patients with cancer according to biological markers. J Neurol Sci. 436: 120246, 2022.

 

●Katsumata R, Neshige S, Nonaka M, Maruyama H.

Enclosed and silent growth of chronic cryptococcal meningitis. BMJ Case Rep. 15(5): e250302, 2022.

 

●Kuroda N, Kubota T, Horinouchi T, Ikegaya N, Kitazawa Y, Kodama S, Kuramochi I, Matsubara T, Nagino N, Neshige S, Soga T, Takayama Y, Sone D, IMPACT-J EPILEPSY study group.

Impact of COVID-19 pandemic on epilepsy care in Japan: A national-level multicenter retrospective cohort study. Epilepsia Open. 7(3): 431-441, 2022.

 

●Ishikawa R, Sugimoto T, Abe T, Ohno N, Giga M, Naito H, Kono T, Nomura E, Yamawaki T.

Double trouble: A case of spinal muscular atrophy type III founcd to be complicated by myasthenia gravis due to subacute dysphagia. Clin Exp Neuroimmunol. 13(4): 290-294, 2022.

 

●Oki R, Izumi Y, Fujita K, Miyamoto R, Nodera H, Sato Y, Sakaguchi S, Nokihara H, Kanai K, Tsunemi T, Hattori N, Hatanaka Y, Sonoo M, Atsuta N, Sobue G, Shimizu T, Shibuya K, Ikeda K, Kano O, Nishinaka K, Kojima Y, Oda M, Komai K, Kikuchi H, Kohara N, Urushitani M, Nakayama Y, Ito H, Nagai M, Nishiyama K, Kuzume D, Shimohama S, Shimohata T, Abe K, Ishihara T, Onodera O, Isose S, Araki N, Morita M, Noda K, Toda T, Maruyama H, Furuya H, Teramukai S, Kagimura T, Noma K, Yanagawa H, Kuwabara S, Kaji R; Japan Early-Stage Trial of Ultrahigh-Dose Methylcobalamin for ALS (JETALS) Collaborators.

Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial. JAMA Neurol. 79(6): 575-583, 2022.

 

●Kurashige T, Morino H, Murao T, Izumi Y, Sugiura T, Kuraoka K, Kawakami H, Torii T, Maruyama H.

TDP-43 Accumulation Within Intramuscular Nerve Bundles of Patients With Amyotrophic Lateral Sclerosis. JAMA Neurol. 79(7): 693-701, 2022.

 

●Shiga Y, Aoki S, Tasaka S, Takeshita J, Kamimura T, Hara N, Shimomura R, Matsushima H, Nakamori M, Nezu T, Imamura E, Mizoue T, Wakabayashi S, Maruyama H.

Diffusion-Weighted Imaging Hyperintensities in Acute and Subacute-Phase Intracerebral Hemorrhage. J Stroke Cerebrovasc Dis. 31(8): 106549, 2022.

 

●Muguruma K, Sugimoto T, Terada Y, Yuan J, Nomura E, Takashima H, Yamawaki T, Kohriyama T, Maruyama H.

A case of retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations: Long-term treatment with repeated courses of immunotherapy. Neurology and Clinical Neuroscience. 10(6): 321-324, 2022.

 

●Neshige S, Nonaka M.

Unique, not psychogenic movements: Painful Leg and Moving Toes Syndrome. Creus. 14(9): e29169, 2022.

 

●Nonaka M, Neshige S, Maruyama H.

Levetiracetam-induced myoclonus following recovery from non-convulsive status epilepticus in an elderly woman. Internal and Emergency Medicine. 17(6): 1829-1830, 2022.

 

●Nishikawa Y, Holobar A, Watanabe K, Takahashi T, Ueno H, Maeda N, Maruyama H, Tanaka S, Hyngstrom AS.

Detecting motor unit abnormalities in amyotrophic lateral sclerosis using high-density surface EMG. Clin Neurophysiol. 142: 262-272, 2022.

 

●Sugimoto T, Neshige S,Aoki S, Ochi K, Ishikawa R, Nonaka M, Nakamori M, Nezu T, Nakamichi K, Yamazaki Y, Maruyama H.

A case of natalizumab-associated progressive multifocal leukoencephalopathy followed by immune reconstitution inflammatory syndrome with difficulty in the timing of immunotherapy. Clin Exp Neuroimmunol. 2022.

 

●Suzuki S, Masuda M, Uzawa A, Nagane Y, Konno S, Suzuki Y, Kubota T, Sugimoto T, Samukawa M, Watanabe G, Ishizuchi K, Akamine H, Onishi Y, Yoshizumi K, Uchi T, Amino I, Ueta Y, Minami N, Kawaguchi N, Kimura T, Takahashi MP, Murai H, Utsugisawa K.

Japan MG Registry: chronological surveys over 10 years. Clin Exp Neuroimmunol. 14(5): 5-12, 2022.

 

●Eto F, Nezu T, Aoki S, Kamimura T, Naito H, Shiga Y, Hosomi N, Maruyama H.

The association between nutritional intake one week after admission and outcome in acute ischemic stroke patients. J Stroke Cerebrovasc Dis. 31(11): 106812, 2022.

 

●Ueno H, Ohno N, Abe T, Kimoto K, Matsuoka C, Giga M, Naito H, Kono T, Takasu M, Kidani N, Yamasaki R, Ichimura K, Nomura E.

Prognosis Prediction Using Magnetic Resonance Spectroscopy and Oligoclonal Bands in Central Nervous System Methotrexate-associated Lymphoproliferative Disorder. Intern Med. 61(24): 3733-3738, 2022.

 

●Kuroda N, Iwayama T, Kubota T, Horinouchi T, Ikegaya N, Kitazawa Y, Kodama S, Matsubara T, Nagino N, Neshige S, Soga T, Sone D, Takayama Y, Kuramochi I, IMPACT-J EPILEPSY.

Post-hoc analysis of a cross-sectional nationwide survey assessing psychological distress in electroencephalography technicians during the COVID-19 pandemic in Japan: Qualitative and quantitative text analysis of open-ended response data. Epilepsy & Seizure. 14(1): 58-70, 2022.

 

●Neshige S, Nonaka M, Ono N, Iryo T, Watanabe T, Yamada H, Mine N, Kikumoto M, Takebayashi Y, Ishibashi H, Toko M, Agari D, Shishido T, Ueno H, Iida K, Maruyama H.

Sustainable, collaborative EEG learning with a nationwide webinar. Epilepsy & Seizure. 14(1): 34-43, 2022.

 

●Neshige S, Katsumata R, Nezu T, Aoki S, Maruyama H.

Screening for non-convulsive status epilepticus with density spectrum array in critical care EEG. QJM.  114(12): 893-894, 2022.

 

●COVIDSurg Collaborative* and GlobalSurg Collaborative (Neshige S)

SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. Anaesthesia. 77(1): 28-39, 2022.

 

●Ishikawa K, Araki M, Nagano Y, Motoda A, Shishido T, Kurashige T, Takahashi T, Morino H, Kawakami H, Matsumoto M, Maruyama H.

Knockdown of optineurin controls C2C12 myoblast differentiation via regulating myogenin and MyoD expressions. Differentiation. 123: 1-8, 2022.

 

●Kubota T, Kuroda N, Horinouchi T, Ikegaya N, Kitazawa Y, Kodama S, Kuramochi I, Matsubara T, Nagino N, Neshige S, Soga T, Takayama Y, Sone D.

Barriers to telemedicine among physicians in epilepsy care during the COVID-19 pandemic: A national-level cross-sectional survey in Japan. Epilepsy Behav. 126: 108487, 2022.

 

●Neshige S, Aoki S, Takebayashi Y, Shishido T, Yamazaki Y, Iida K, Maruyama H.

A longitudinal seizure outcome following the COVID-19 pandemic in 2020 and 2021: Transient exacerbation or sustainable mitigation. J Neurol Sci. 434: 120100, 2022.

 

●Naito H, Nezu T, Hosomi N, Kuzume D, Aoki S, Morimoto Y, Yoshida T, Kamimura T, Shiga Y, Kinoshita N, Ueno H, Morino H, Maruyama H.

Increased Serum Alkaline Phosphatase and Functional Outcome in Patients with Acute Ischemic Stroke Presenting a Low Ankle-Brachial Index. J Atheroscler Thromb. 29(5): 719-730, 2022.

 

●Kikumoto M, Neshige S, Shishido T, Ueno H, Aoki S, Iida K, Maruyama H.

Seizure Deterioration with Increased Levetiracetam Blood Concentration During the Postpartum Period in Refractory Temporal Lobe Epilepsy. Intern Med.  61(8): 1237-1240, 2022.

 

●Ishikawa R, Sugimoto T, Abe T, Ohno N, Tazuma T, Giga M, Naito H, Kono T, Nomura E, Hara K, Yorifuji T, Yamawaki T.

A 36-year-old Man with Repeated Short-term Transient Hyperammonemia and Impaired Consciousness with a Confirmed Carbamoyl Phosphate Synthase 1 Gene Monoallelic Mutation. Intern Med. 61(9): 1387-1392, 2022.

 

●Araki H, Uchida K, Yoshimura S, Kurisu K, Shime N, Sakamoto S, Aoki S, Ichinose N, Kajihara Y, Tominaga A, Naka H, Mizoue T, Sumida M, Hirotsune N, Nomura E, Matsushige T, Kanazawa J, Kato Y, Kawamoto Y, Kuroki K, Morimoto T.

Effect of region-wide use of prehospital stroke triage scale on management of patients with acute stroke. J Neurointerv Surg. 14(7): 677-682, 2022.

 

●Nezu T, Hosomi N, Naito H, Aoki S, Torii T, Kurashige T, Sugiura T, Kuzume D, Morimoto Y, Yoshida T, Yagita Y, Oyama N, Shiga Y, Kinoshita N, Kamimura T, Ueno H, Ohshita T, Maruyama H.

Clinical characteristics and tumor markers in ischemic stroke patients with active cancer. Internal and Emergency Medicine. 17(3): 735-741,2022.

 

●Shiga Y, Nezu T, Shimomura R, Sato K, Himeno T, Terasawa Y, Aoki S, Hosomi N, Kohriyama T, Maruyama H.

Various effects of nutritional status on clinical outcomes after intracerebral hemorrhage. Intern Emerg Med. 17(4): 1043-1052, 2022.

 

●Nezu T, Hosomi N, Yoshimura K, Kuzume D, Naito H, Aoki S, Morimoto Y, Kinboshi M, Yoshida T, Shiga Y, Kinoshita N, Furui A, Tabuchi G, Ueno H, Tsuji T, Maruyama H.

Predictors of Stroke Outcome Extracted from Multivariate Linear Discriminant Analysis or Neural Network Analysis. J Atheroscler Thromb. 29(1): 99-110, 2022.

 

●Nezu T, Hosomi N, Yoshimura K, Kuzume D, Naito H, Aoki S, Morimoto Y, Kinboshi M, Yoshida T, Shiga Y, Kinoshita N, Furui A, Tabuchi G, Ueno H, Tsuji T, Maruyama H.

Predictors of Stroke Outcome Extracted from Multivariate Linear Discriminant Analysis or Neural Network Analysis. J Atheroscler Thromb. 29(1): 99-110, 2022.